If approved, Awiqli would become the first once-weekly basal insulin available in the United States for adults with Type 2 ...

After launching a multi-campus phased rollout of the predictive insulin dosing software, Philadelphia-based Temple Health’s University Hospital has reduced hypoglycemia rates two- to threefold.   The ...

Say goodbye to inflammation and hello to better blood sugar in this simple diabetes-friendly plan for beginners.

Tandem Diabetes Care announced today that it received approval to deliver Lyumjev ultra-rapid acting insulin with its t:slim ...